VACCINEX, INC. (VCNX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 350K 700K 1.1M FY20: 625K FY21: 900K FY22: 275K FY23: 570K FY24: 601K FY20 FY21 FY22 FY23 FY24

Gross Profit Annual

-500K -250K 0 250K 500K 750K FY17: -70K FY18: -309K FY19: 324K FY20: 623K FY17 FY18 FY19 FY20

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

-30M -20M -10M 0 10M 20M 30M FY20: -28.3M FY21: -22.5M FY22: -19.9M FY23: -22.9M FY24: -18.7M FY20 FY21 FY22 FY23 FY24

Net Income Annual

-30M -20M -10M 0 10M 20M 30M FY20: -28.9M FY21: -22.4M FY22: -19.8M FY23: -20.3M FY24: -18.6M FY20 FY21 FY22 FY23 FY24

Cost of Revenue Annual

0 400K 800K 1.2M FY17: 160K FY18: 1M FY19: 199K FY20: 2K FY17 FY18 FY19 FY20

Operating Cash Flow Annual

-30M -20M -10M 0 10M 20M 30M FY20: -28.6M FY21: -25.3M FY22: -19.1M FY23: -21.4M FY24: -16.2M FY20 FY21 FY22 FY23 FY24

Free Cash Flow Annual

-30M -20M -10M 0 10M 20M 30M FY20: -28.9M FY21: -25.3M FY22: -19.2M FY23: -21.4M FY24: -16.2M FY20 FY21 FY22 FY23 FY24

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 10M 20M 30M FY21: 28.8M FY22: 202.1K FY23: 463.7K FY24: 2.1M FY21 FY22 FY23 FY24

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-180.00 -120.00 -60.00 0.00 60.00 120.00 180.00 Q1 '20: -2.16 Q2 '20: -1.78 Q3 '20: -1.66 Q4 '20: -1.55 Q1 '21: -1.36 Q2 '21: -1.18 Q3 '21: -0.91 Q4 '21: -0.79 Q1 '22: -0.65 Q2 '22: -0.57 Q3 '22: -2.07 Q4 '22: -94.63 Q1 '23: -115.40 Q2 '23: -139.81 Q3 '23: -153.39 Q4 '23: -43.68 Q1 '24: -25.73 Q2 '24: -4.29 Q3 '24: 8.13 Q4 '24: -8.90 Q2 '20 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.